AMGN 📈 Amgen - Overview

Amgen Inc. is a multinational biopharmaceutical company that engages in the discovery, development, manufacturing, and delivery of human therapeutics globally. The company's product portfolio includes a range of innovative medicines, such as Enbrel, which is used to treat various autoimmune diseases, including plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. Additionally, Amgen offers Otezla, a treatment for adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. The company also markets Prolia, a medication designed to treat postmenopausal women with osteoporosis, as well as XGEVA, which is used to prevent skeletal-related events.

Amgen's product lineup also includes Repatha, a cholesterol-lowering medication that reduces the risks of myocardial infarction, stroke, and coronary revascularization. The company also offers Nplate, a treatment for patients with immune thrombocytopenia, a rare blood disorder. Furthermore, Amgen markets KYPROLIS, a medication used to treat patients with relapsed or refractory multiple myeloma, a type of blood cancer. Other notable products include Aranesp, which treats anemia and a lower-than-normal number of red blood cells, and EVENITY, a medication used to treat osteoporosis in postmenopausal women and men. The company's portfolio also comprises Vectibix, a treatment for patients with wild-type RAS metastatic colorectal cancer, and BLINCYTO, a medication used to treat patients with acute lymphoblastic leukemia.

In addition to its core products, Amgen has a range of other medications, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA, and PROCYSBI. These products cater to various therapeutic areas, including oncology, cardiovascular disease, and inflammatory diseases. Amgen serves a diverse range of healthcare providers, including physicians, clinics, dialysis centers, hospitals, and pharmacies, and distributes its products through pharmaceutical wholesale distributors and direct-to-consumer channels. The company has established collaboration agreements with several major pharmaceutical companies, including AstraZeneca, Novartis, UCB, Kyowa Kirin, and BeiGene, to develop and commercialize new treatments.

Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. The company is listed on the NASDAQ stock exchange under the ticker symbol AMGN and is classified as a common stock. With a strong focus on innovation and research, Amgen is committed to developing new treatments that address significant unmet medical needs. The company's website provides detailed information about its products, research, and mission, and can be accessed at https://www.amgen.com. Amgen's ISIN is US0311621009, and it operates in the biotechnology sub-industry, which is a key sector within the healthcare industry.